MENU
SEP 13, 2016 12:30 PM PDT

Defining Best Practices for Urinalysis Diagnostics in a Value-Based Healthcare System

Sponsored by: Arkray, Arkray
Speaker
  • Medical Director Core Laboratory & Laboratory Informatics, Laboratory Medicine
    Biography
      Dr. Skelton is a Board Certified Clinical Pathologist who received a BS from MIT and MD PhD degrees from Washington University in St. Louis. Residency & Fellowship training were completed at Massachusetts General Hospital. Dr. Skelton is a leader in the implementation of new approaches to the clinical practice of Laboratory Medicine that impact the economics and outcomes of patient care. He has combined his NIH-funded research, industry collaboration, and advanced information technology to develop lab-based algorithms that maximize an integrated healthcare system's ability to deliver high-quality low-cost patient care. Areas of expertise include Hematology, Coagulation, Cancer Biomarkers, Endocrinology, Critical Care, Urinalysis, and Chemistry. Dr. Skelton teaches a graduate course on Clinical Laboratory Quality in the Clinical Laboratory Sciences Department at University of Massachusetts Lowell.

    Abstract
    Urinalysis is one the oldest, most established, and most frequently ordered laboratory tests.  However, there is wide variation in the methods, processes, quality checks, specifications, and diagnostic scope in clinical use today.  Dr. Skelton will describe his experience with a focused systematic effort to identify and implement best practices in all aspects of urinalysis testing at Lahey Health.  Decisions on best practice were made with the goal of optimizing clinical benefit to Lahey Health’s patient population and reducing the total healthcare cost attributable to the burden of diseases evaluated by urinalysis.  Changes to institutional policies combined with novel application of information technology were applied to overcome perceived regulatory obstacles to optimal evidence-based clinical practice.  Best practices for order design, result reporting, and data architecture and their impact on workflow efficiencies will be discussed.  Recent technical advances in instrumentation allow improved diagnostic abilities that enable a redesign of the laboratory process and clinical scope of urinalysis.  Data will demonstrate the impact that this type of redesign has had at Lahey Health. 
     
    Learning Objectives:
    After attending this session, participants will be able to:
    • 1 Understand the variables that impact the clinical diagnostic performance of urinalysis testing
    • 2 Identify key developments in instrumentation, information technology, and healthcare delivery that improve the value of urinalysis diagnostics

    Show Resources
    You May Also Like
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    DEC 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    AUG 18, 2020 10:00 AM PDT
    C.E. CREDITS
    AUG 18, 2020 10:00 AM PDT
    DATE: August 18, 2020 TIME: 10:00am PT Get deeper understanding of gene expression patterns by using assays that retain spatial organization at single cell resolution! Come learn about the n...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    Loading Comments...
    Show Resources
    Attendees
    • See more